Phase II trial of coumarin and cimetidine in advanced renal cell carcinoma.
Herrmann
R
R
Medizinische Klinik und Poliklinik, Klinikum Rudolph Virchow, Freien Universität Berlin, FRG.
Manegold
C
C
Maurer
B
B
Hennig
F W
FW
Matthiessen
W
W
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000401:mortality / Q000556:secondary; D002927:Cimetidine / Q000008:administration & dosage; D003374:Coumarins / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D010997:Pleural Neoplasms / Q000556:secondary; D015996:Survival Rate
D003374:Coumarins; D002927:Cimetidine; C030123:coumarin